Form D · Pharmaceuticals

LivFul Inc.

Temple, TX · CIK 0001845848

Offering snapshot reported Dec 16, 2025 · SEC filing

Reported sold
$250K
Offering amount: $26M
Investors reported
2
Form D · investor count
Minimum accepted
$250K
Reported outside-investor minimum
First sale
Dec 8, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 16, 2025Initial$250,000No comparison2SEC filing
Jun 7, 2024Initial$125,000No comparison1SEC filing
Apr 5, 2023Amendment$3,102,750$2,352,750vs May 3, 202213SEC filing
May 3, 2022Initial$750,000No comparison1SEC filing
Mar 24, 2021Initial$6,660,000No comparison60SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-567012

Source: Form D, filed Dec 16, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Andrew Barlow Director
Hogan Bassey Director, Executive
Matt Elsberry Director, Executive
Kevin Engel Director, Executive
Wesley Lyons Director
John Manwell Director, Executive
Kris Maynard Director
Michael Norman Director, Executive
Yaw Nsarkoh Director
Dave Rae Director
Carl Thong Director
Francis Yip Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
6 S. 1 St Street, Suite 225
Temple, TX, 76501
Phone: 254-624-5747